Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06773286 · ClinicalTrials.gov registry record · NA

Combining Spinal Cord Transcutaneous Stimulation and Activity-based Training in Inpatient Rehabilitation to Facilitate Upper Limb Function of Individuals with Acute to Subacute Cervical Spinal Cord Injury

A NA study of Spinal Cord Injury Cervical, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06773286: Recruiting NA study of Spinal Cord Injury Cervical, sponsored by Kessler Foundation.

NCT06773286 is a NA study of Spinal Cord Injury Cervical that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 30 participants, above the 18-participant average among 12 other Spinal Cord Injury Cervical trials with a reported enrollment target (67% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06773286, a NA study of Spinal Cord Injury Cervical, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to understand the safety and practicality of using spinal cord transcutaneous (through the skin) stimulation in an inpatient setting as well as how the combination of activity-based training (ABT) and spinal cord transcutaneous stimulation (scTS) can improve participants' ability to use their hands, arms, and trunk in an inpatient rehabilitation program. The main questions it aims to answer are: * Is the combination of spinal cord transcutaneous stimulation and ABT is safe and practical when applied to individuals with acute to subacute cervical SCI during inpatient rehabilitation? * How the combined intervention can improve hand and arm function when applied to those individuals? The investigators will assess the safety, feasibility, and preliminary efficacy of the combined intervention and compare to a sham control (sham stimulation combined with ABT) and a ABT only group to see if the combined intervention can lead to greater function recovery. Participants will: * Receive one type of the three intervention (scTS+ABT, sham scTS+ABT, or ABT only) for 10 sessions with 30 mins/session over 2 weeks. * Receive assessment before, during, and immediately after the intervention, and at 1-month, 2-month, and 3-month follow-up visits.

Primary Outcome

Subjects will be asked to rate their pain intensity using an 11-point Numerical Rating Scale (i.e. 0-10), before and after each intervention session. The change in pain will be documented.

Interventions

  • OTHER Sham
  • OTHER Active Stimulation
  • OTHER Training only

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-04-08
Est. Completion 2025-12
Phase NA
Kessler Foundation

104 total trials

What NCT06773286 shows while recruiting

NCT06773286 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, above the 18-participant average among 12 other Spinal Cord Injury Cervical trials with a reported enrollment target (67% higher).

The record links to 1 condition, with Spinal Cord Injury Cervical appearing as the primary indexed condition, and to 3 interventions - of which Sham is the first listed.

NCT06773286 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06773286 about?

NCT06773286 is a clinical study titled "Combining Spinal Cord Transcutaneous Stimulation and Activity-based Training in Inpatient Rehabilitation to Facilitate Upper Limb Function of Individuals with Acute to Subacute Cervical Spinal Cord Injury". The purpose of this clinical trial is to understand the safety and practicality of using spinal cord transcutaneous (through the skin) stimulation in an inpatient setting as well as how the combination of activity-based training (ABT) and spinal cord transcutaneous stimulation (scTS) can improve par...

What is the current status of trial NCT06773286?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-04-08. Estimated completion is 2025-12.

What conditions does trial NCT06773286 study?

This clinical trial studies the following conditions: Spinal Cord Injury Cervical.

What interventions are being tested in trial NCT06773286?

The interventions under investigation include: Sham (OTHER), Active Stimulation (OTHER), Training only (OTHER).

Who is sponsoring clinical trial NCT06773286?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06773286 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury Cervical

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06773286's enrollment target sits among peer trials

30 2nd of 12 higher than 10 of 12 other Spinal Cord Injury Cervical trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injury Cervical trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06773286, the US trial registry maintained by the National Library of Medicine. NCT06773286 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.